|本期目录/Table of Contents|

[1]王 丹,李文思,成苏杭,等.Treg/Th17及DC细胞水平在COPD不同疾病进展期的表达及其与预后的关系[J].中华肺部疾病杂志,2024,(05):685-689.[doi:10.3877/cma.j.issn.1674-6902.2024.05.003]
　Wang Dan,Li Wensi,Cheng Suhuang,et al.Expression of Treg/Th17 and DC cells in different COPD progression stages and their relationships with prognosis[J].,2024,(05):685-689.[doi:10.3877/cma.j.issn.1674-6902.2024.05.003]
点击复制

Treg/Th17及DC细胞水平在COPD不同疾病进展期的表达及其与预后的关系(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年05期
页码:
685-689
栏目:
论著
出版日期:
2024-10-25

文章信息/Info

Title:
Expression of Treg/Th17 and DC cells in different COPD progression stages and their relationships with prognosis
作者:
王 丹; 李文思; 成苏杭; 吉 泽; 朱 祥; 郝春艳
215028 苏州,上海交通大学医学院苏州九龙医院呼吸与危重症医学科
Author(s):
Wang Dan;  Li Wensi;  Cheng Suhuang;  Ji Ze;  Zhu Xiang;  Hao Chunyan.
Department of Respiratory and Critical Care Medicine,Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, ChinA
关键词:
肺疾病; 慢性阻塞性;  调节性T细胞;  辅助性T细胞17;  树突细胞;  预后
Keywords:
Chronic obstructive pulmonary disease;  Regulatory T cell;  T helper cell 17;  Dendritic cell;  Prognosis
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2024.05.003
摘要:
目的 分析调节性T细胞(regulatory T cell, Treg)/辅助性T细胞17(T helper cell 17, Th17)及树突细胞(dendritic cell, DC)水平在慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)不同疾病进展期的表达及与预后的关系。方法 选择2019年9月至2023年2月我院收治的73例COPD患者为对象,35例急性加重期为观察组,38例稳定期为对照组,比较两组CT影像参数[支气管壁面积百分比(percentage of wall area, WA%)、支气管管腔面积(bronchial lumen area, Ai)]、Treg、Th17、Treg/Th17及DC细胞水平; 通过Spearman相关系数分析Treg、Th17、Treg/Th17及DC细胞水平与COPD病情严重程度之间的相关性; 随访6个月,比较不同预后患者资料[包括性别、年龄、体质量指数(body mass index, BMI)、病程、基础疾病]及Treg、Th17、Treg/Th17及DC细胞; 以ROC分析Treg、Th17、Treg/Th17及DC细胞判断预后不良。结果 观察组Ai(8.76±2.45)mm2低于对照组(14.97±3.61)mm2,WA%(77.62±7.74)%高于对照组(66.81±7.04)%(P<0.05)。观察组Treg(2.59±0.54)%、Treg/Th17(0.41±0.11)、DC细胞水平(1.38±0.41)%低于对照组(4.38±0.77)%、(0.82±0.26)、(2.52±0.82)%,观察组Th17水平(6.28±0.99)%高于对照组(5.32±0.63)%(P<0.05)。Treg、Treg/Th17、DC细胞与病情严重程度呈负相关(r=-0.563、-0.571、-0.536,P<0.05),Th17与病情严重程度呈正相关(r=0.542,P<0.05)。随访6个月,预后良好59例,预后不良14例。预后良好者Treg(3.87±1.22)%、Treg/Th17(0.69±0.21)、DC细胞水平(2.33±0.52)%高于预后不良者(2.38±0.75)%、(0.34±0.11)、(1.92±0.32)%,Th17水平(5.64±1.15)%低于预后不良者(6.91±1.42)%(P<0.05)。ROC结果显示,Treg、Th17、Treg/Th17及DC细胞判断预后不良的曲线下面积分别为0.856、0.702、0.825、0.790,P<0.05。结论 Treg/Th17及DC细胞水平在COPD稳定期及急性加重期呈高表达,Treg/Th17、DC细胞水平升高对COPD的预后具有意义。
Abstract:
Objective To analyze the expression of regulatory T cells(Treg)/T helper cells 17(Th17)and dendritic cells(DC)in different progression stages of chronic obstructive pulmonary disease(COPD)and their relationships with prognosis. Methods The clinical data of 73 patients with COPD admitted to Suzhou Jiulong Hospital, Shanghai Jiaotong University School of Medicine from September 2019 to February 2023 were retrospectively analyzed. Among them, 35 patients in the acute exacerbation stage were included in the observation group, and 38 patients in the stable stage were included in the control group. The levels of CT image parameters [percentage of wall area(WA%), bronchial lumen area(Ai)], Treg, Th17, Treg/Th17 and DC cells were detected, and the patients was divided into good prognosis(77 cases)and poor prognosis(18 cases)according to the follow-up results. The levels of Treg, Th17, Treg/Th17 and DC cells in stable group, exacerbation group and control group were compared; Spearman correlation coefficient was used to analyze the correlation between the levels of Treg, Th17, Treg/Th17, DC cells and the severity of COPD; the general data [including sex, age, body mass index(BMI), course of disease, underlying diseases] and the levels of Treg, Th17, Treg/Th17 and DC cells of the good prognosis group and the poor prognosis group were compared; ROC analysis was used to analyze the value of Treg, Th17, Treg/Th17 and DC cells in evaluating the poor prognosis of patients. Results The Ai[(8.76±2.45)mm2] of the observation group was significantly lower than that of the control group [(14.97±3.61)mm2], and the WA%(77.62±7.74)% was significantly higher than that of the control group [(66.81±7.04)%](P<0.05). The levels of Treg, Treg/Th17 and DC cells in observation group [(2.59±0.54)%,(0.41±0.11),(1.38±0.41)%] were significantly lower than those in control group [(4.38±0.77)%,(0.82±0.26),(2.52±0.82)%], and the levels of Th17 in observation group [(6.28±0.99)%] were significantly higher than those in control group [(5.32±0.63)%](P<0.05). Treg, Treg/Th17 and DC cells were negatively correlated with the severity of the disease(r=-0.563,-0.571,-0.536, P<0.05), and Th17 was positively correlated with the severity of the disease(r=0.542, P<0.05). The levels of Treg, Treg/Th17 and DC cells in the good prognosis group [(3.87±1.22)%,(0.69±0.21),(2.33±0.52)%] were significantly higher than those in the poor prognosis group [(2.38±0.75)%,(0.34±0.11),(1.92±0.32)%], and the level of Th17 in the good prognosis group [(5.64±1.15)%] was significantly lower than that in the poor prognosis group [(6.91±1.42)%](P<0.05). ROC results showed that the area under the curve of Treg, Th17, Treg/Th17 and DC cells to evaluate the poor prognosis of patients was 0.856, 0.702, 0.825 and 0.790, respectively(P<0.05). Conclusion The levels of Treg/Th17 and DC cells were highly expressed in both stable and acute exacerbations of COPD, and the levels of Treg/Th17 and DC cells in the good prognosis group were significantly higher than those in the poor prognosis group.

参考文献/References:

1 陈华萍, 甘志新, 刘 刚, 等. 慢性阻塞性肺疾病的合并症/并发症的发病率和病死率分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(4): 417-421.
2 Wang YQ, Li PJ, Cao YY, et al. Skeletal muscle mitochondrial dysfunction in chronic obstructive pulmonary disease: underlying mechanisms and physical therapy perspectives[J]. Aging Dis, 2023, 14(1): 33-45.
3 郝月琴, 王 欣, 李 猛, 等. 慢性阻塞性肺疾病患者T细胞亚群变化及CD8+ CD28+ T细胞与C反应蛋白相关性探讨[J]. 中国呼吸与危重监护杂志, 2020, 19(1): 75-77.
4 Huang SX, He Q, Zhou LF. T cell responses in respiratory viral infections and chronic obstructive pulmonary disease[J]. Chin Med J(Engl), 2021, 134(13): 1522-1534.
5 Ma R, Su HL, Jiao KP, et al. Role of Th17 cells, Treg cells, and Th17/Treg imbalance in immune homeostasis disorders in patients with chronic obstructive pulmonary disease[J]. Immun Inflamm Dis, 2023, 11(2): e784.
6 Velikova TV, Miteva L, Stanilov N, et al. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer[J]. World J Gastroenterol, 2020, 26(16): 1912-1925.
7 Leng S, Xu W, Wu L, et al. NLRP3 disturbs treg/th17 cell balance to aggravate apical periodontitis[J]. J Dent Res, 2023, 102(6): 656-666.
8 Thomas R, Qiao S, Yang X. Th17/Treg imbalance: implications in lung inflammatory diseases[J]. Int J Mol Sci, 2023, 24(5): 4865.
9 Hassannia H, Chaleshtari MG, Atyabi F, et al. Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine[J]. Immunology, 2020, 159(1): 75-87.
10 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等.慢性阻塞性肺疾病基层诊疗指南(2018年)[J]. 中华全科医师杂志, 2018, 17(11): 856-870.
11 Cho MH, Hobbs BD, Silverman EK. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder[J]. Lancet Respir Med, 2022, 10(5): 485-496.
12 Lin ZW, Xu YF, Guan LL, et al. Seven ferroptosis-specific expressed genes are considered as potential biomarkers for the diagnosis and treatment of cigarette smoke-induced chronic obstructive pulmonary disease[J]. Ann Transl Med, 2022, 10(6): 331.
13 胡亭亭, 肖祖克. miRNAs在慢性阻塞性肺疾病中的研究进展[J]. 国际病理科学与临床杂志, 2016, 35(7): 1018-1023.
14 张绍塘, 陈 伦, 叶 健. 多索茶碱联合盐酸氨溴索对老年稳定期慢阻肺患者血清IL-33/sST2轴表达的影响[J]. 中国临床药理学杂志, 2022, 38(4): 291-295.
15 崔金霞, 马维秀, 肖 迪. 老年COPD患者多索茶碱联合BiPAP辅助治疗的临床效果[J]. 中国老年学杂志, 2020, 40(19): 4123-4126.
16 王 强, 罗 勇. 不同HRCT表型慢性阻塞性肺疾病患者呼吸功能和HRCT定量指标的对比研究[J]. 中国现代医学杂志, 2020, 30(13): 62-66.
17 张 凤, 方 著, 袁 艺, 等. 慢性阻塞性肺疾病患者HRCT定量指标与肺功能的相关性研究[J]. 天津医药, 2023, 51(3): 320-325.
18 汪嘉佳, 李 哲, 江继发, 等. 外周血Treg细胞、Th17细胞在成人原发性免疫性血小板减少症中的变化及意义[J]. 山东医药, 2021, 61(28): 74-77.
19 刘韩韩, 朱 蕾. Th17/Treg在慢性阻塞性肺疾病中的研究进展[J]. 复旦学报(医学版), 2023, 50(1): 147-153.
20 邝向东, 刘 畅, 王成存, 等. Th1/Th2和Th17/Treg平衡与COPD合并下呼吸道感染的关系[J]. 中华医院感染学杂志, 2022, 32(3): 394-398.
21 王 萍, 林 羽, 李 合. Th17/Treg炎性细胞因子对自身免疫性疾病合并肺部感染病情的评估价值[J]. 中华医院感染学杂志, 2022, 32(6): 866-870.
22 罗 平, 辛艳梅, 郭渠莲, 等. miR-142在儿童自身免疫性甲状腺疾病中表达及与Th17/Treg失衡关系的研究[J]. 中国当代儿科杂志, 2024, 26(6): 605-610.
23 张甲倩, 张升校, 乔 军, 等. 风湿性疾病患者外周血CD4+ T细胞亚群特征及其对免疫调节联合治疗的反应[J]. 中华风湿病学杂志, 2021, 25(6): 368-372.
24 宋伟伟, 常双喜, 禹彩霞, 等. 慢性阻塞性肺疾病合并肺部感染者Th17/Treg、IL-17水平与肺功能及CAT评分的关系[J]. 中国老年学杂志, 2022, 42(8): 1843-1846.
25 伊 刚, 赵 毅, 解 丰, 等. 单细胞RNA测序揭露人FOXP3^+调节性T细胞稳定性的关键调控分子[J]. 科学通报:英文版, 2020, 65(13): 1114-1124.
26 刘兆阳. 外周血Th17/Treg失衡与老年稳定期COPD患者肺功能及急性加重的相关性[J]. 中国老年学杂志, 2021, 41(6): 1199-1203.
27 刘 朋, 邱书奇, 胡田勇, 等. 免疫耐受型树突状细胞对变应性鼻炎免疫调节的研究进展[J]. 中国现代医学杂志, 2022, 32(23): 53-59.

备注/Memo

备注/Memo:
基金项目: 上海市科学技术委员会科研计划资助项目(19401933200)
通信作者: 郝春艳, Email: 13962145339@163.com
更新日期/Last Update: 2024-10-25